Pharmacokinetics of nalbuphine hydrochloride after intravenous and intramuscular administration to Hispaniolan Amazon parrots Amazona ventralis

American Journal of Veterinary Research

Volumn 72, Issue 6, 2011, Pages 741-745

  Keller, Dominique L ^a   Guzman, David Sanchez Migallon ^a,d   Klauer, Julia M ^a   Kukanich, Butch ^b   Barker, Steven A ^c   Fernández, Julia Rodríguez Ramos ^a   Paul Murphy, Joanne R ^d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALBUPHINE;

AMAZONA VENTRALIS; ARTICLE; CONTROLLED STUDY; DOSIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSAGE FORM COMPARISON; DRUG HALF LIFE; HALF LIFE TIME; LIQUID CHROMATOGRAPHY; NONHUMAN; PARROT; RANDOMIZED CONTROLLED TRIAL; TANDEM MASS SPECTROMETRY;

ANALGESICS, OPIOID; ANIMALS; AREA UNDER CURVE; BIRD DISEASES; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; NALBUPHINE; PAIN; PARROTS;

AMAZONA; AMAZONA VENTRALIS; ANIMALIA; AVES; PSITTACIDAE; PSITTACIFORMES;

EID: 79958069378     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.6.741     Document Type: Article

References (33)

1. Clyde V, Paul-Murphy J. Avian analgesia. In: Fowler M, MillerR, eds. Zoo & wild animal medicine. 4th ed. Philadelphia: WBSaunders Co, 1999;309-314.
2. Hoppes S, Flammer K, Hoersch K, etal. Disposition and analgesiceffects of fentanyl in white cockatoos (Cacatua alba). J AvianMed Surg 2003;17:124-130.
3. Paul-Murphy JR, Brunson DB, Miletic V. Analgesic effects of butorphanoland buprenorphine in conscious African grey parrots(Psittacus erithacus erithacus and Psittacus erithacus timneh). AmJ Vet Res 1999;60:1218-1221.
4. Curro TG, Brunson DB, Paul-Murphy J. Determination of theED50 of isoflurane and evaluation of the isoflurane-sparingeffect of butorphanol in cockatoos (Cacatua spp.). Vet Surg1994;23:429-433.
5. Mansour A, Khachaturian H, Lewis ME, et al. Anatomy of CNSopioid receptors. Trends Neurosci 1988;11:308-314.
6. Paul-Murphy J, Sladky KK, Krugner-Higby L, et al. Analgesiceffects of carprofen and liposome-encapsulated butorphanoltartrate in Hispaniolan parrots (Amazona ventralis) with experimentallyinduced arthritis. Am J Vet Res 2009;70:1201-1210.
7. Buchwalder T, Huber-Eicher B. Effect of the analgesic butorphanolon activity behaviour in turkeys (Meleagris gallopavo). ResVet Sci 2005;79:239-244.
8. Paul-Murphy J, Krugner-Higby L, Tourdot R, et al. Evaluationof liposome-encapsulated butorphanol tartrate for alleviation ofexperimentally induced arthritic pain in green-cheeked conures(Pyrrhura molinae). Am J Vet Res 2009;70:1211-1219.
9. Sladky KK, Krugner-Higby L, Meek-Walker E, et al. Serumconcentrations and analgesic effects of liposome-encapsulatedand standard butorphanol tartrate in parrots. Am J Vet Res2006;67:775-781.
10. Gaynor JS, Muir WW III. Handbook of veterinary pain management.2nd ed. St Louis: Mosby, 2008.
11. Branson KR, Gross ME. Opioid agonists and antagonists. In:Adams H, ed. Veterinary pharmacology and therapeutics. 8th ed.Ames, Iowa: Iowa State Press, 2001;268-298.
12. Liu KS, Hu OY, Ho ST, et al. Antinociceptive effect of a novel longactingnalbuphine preparation. Br J Anaesth 2004;92:712-715.
13. Chu KS, Wang JJ, Hu OY, et al. The antinociceptive effect ofnalbuphine and its long-acting esters in rats. Anesth Analg2003;97:806-809.
14. Flecknell P, Liles J. Assessment of the analgesic action ofopioid agonist-antagonists in the rabbit. J Assoc Vet Anaesth1990;17:24-29.
15. Sawyer DC, Rech RH. Analgesia and behavioral effects of butorphanol,nalbuphine, and pentazocine in the cat. J Am Anim HospAssoc 1987;23:438-446.
16. Wagner AE, Worland GA, Glawe JC, et al. Multicenter, randomizedcontrolled trial of pain-related behaviors following routineneutering in dogs. J Am Vet Med Assoc 2008;233:109-115.
17. Ho ST, Wang JJ, Hu OY, et al. The effect of aging on the pharmacokineticsof nalbuphine in rabbits. Biopharm Drug Dispos1995;16:695-703.
18. Pao L, Hsiong C, Hu OY, et al. In vitro and in vivo evaluationof the metabolism and pharmacokinetics of sebacoyl dinalbuphine.Drug Metab Dispos 2005;33:395-402.
19. Lo MW, Lee FH, Schary WL, et al. The pharmacokinetics ofintravenous, intramuscular, and subcutaneous nalbuphine inhealthy subjects. Eur J Clin Pharmacol 1987;33:297-301.
20. Leung GNW, Leung DKK, Wan TSM, et al. High throughputscreening of sub-ppb levels of basic drugs in equine plasmaby liquid chromatography-tandem mass spectrometry. J ChromatogrA 2007;1156:271-279.
21. Sanchez-Migallon Guzman D, Flammer K, Paul-Murphy J, et al. Pharmacokinetics of butorphanol after oral, intravenous andintramuscular administration in Hispaniolan Amazon parrots(Amazona ventralis). J Avian Med Surg 2011;25:250-259.
22. Pao L, Hsiong C, Hu OY, et al. High-performance liquid chromatographicmethod for the simultaneous determination of nalbuphineand its prodrug, sebacoyl dinalbuphine ester, in dogplasma and application to pharmacokinetic studies in dogs.J Chromatogr B 2000;746:241-247.
23. Gunion MW, Marchionne AM, Anderson CTM. Use of themixed agonist-antagonist nalbuphine in opioid based analgesia.Acute Pain 2004;6:29-39.
24. Sanchez-Migallon Guzman D, KuKanich B, Keuler NS, et al.Antinociceptive effects of nalbuphine hydrochloride in HispaniolanAmazon parrots (Amazona ventralis). Am J Vet Res Assoc2011;72:736-740.
25. Flecknell P. Developments in the veterinary care of rabbits androdents. In Pract 1998;20:286-295.
26. Schmidt WK, Tam SW, Shotzberger GS, et al. Nalbuphine. DrugAlcohol Depend 1985;14:339-362.
27. Pallasch TJ, Gill CJ. Butorphanol and nalbuphine: a pharmacologiccomparison. Oral Surg Oral Med Oral Pathol 1985;59:15-20.
28. van den Berg AA, Nandagopal M, Qureshi SA, et al. The use oflignocaine to reduce pain on i.v. injection of diluted nalbuphine.Eur J Anaesthesiol 1995;12:513-516.
29. Cohen RI, Edwards WT, Kezer EA, et al. Serial intravenousdoses of dezocine, morphine, and nalbuphine in the managementof postoperative pain for outpatients. Anesth Analg1993;77:533-539.
30. Riggs SM, Hawkins MG, Craigmill AL, et al. Pharmacokineticsof butorphanol tartrate in red-tailed hawks (Buteo jamaicensis)and great horned owls (Bubo virginianus). Am J Vet Res2008;69:596-603.
31. Hunter RP, Isaza R. Concepts and issues with interspecies scalingin zoological pharmacology. J Zoo Wildl Med 2008;39:517-526.
32. Hunter RP, Mahmood I, Martinez MN. Prediction of xenobioticclearance in avian species using mammalian or avian data: howaccurate is the prediction? J Vet Pharmacol Ther 2008;31:281-284.
33. Aungst BJ, Myers MJ, Shefter E, et al. Prodrugs for improvedoral nalbuphine bioavailability: inter-species differences in thedisposition of nalbuphine and its acetylsalicylate and anthranilateesters. Int J Pharm 1987;38:199-209.